Clinical Trials Directory

Trials / Completed

CompletedNCT05687669

Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
170 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Severe pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid control of blood pressure showed to provide protection against many adverse effects of preeclampsia as intracranial hemorrhage, subcapsular hepatic hematoma and acute kidney injury (AKI). In Assiut university hospital ICU regimen, glyceryl trinitrate (GTN) was used primarily for this purpose. But it was accused in many cases as a cause for AKI without any other organ damage along with the severe preeclampsia disease. Some previous studies supported this assumption as , Ying-Hsuan .T. et.,al during their study of GTN on renal outcome during cardiopulmonary bypass in cardiac surgery. Phentolamine infusion is a new rising alternative for an old drug with a high safety profile. In this research protocol the researchers will study comparative effect of glyceryl trinitrate (GTN) versus phentolamine on renal outcome in severe pre-eclampsia patients during their stay in obstetric ICU.

Conditions

Interventions

TypeNameDescription
DRUGGlyceryl trinitrate vs phentolamine for prophylaxis against renal impairmentGlyceryl trinitrate vs phentolamine for prophylaxis against renal impairment

Timeline

Start date
2023-01-12
Primary completion
2023-04-12
Completion
2023-06-12
First posted
2023-01-18
Last updated
2025-12-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05687669. Inclusion in this directory is not an endorsement.